Beam Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Beam Therapeutics Inc. (BEAM) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Current Assets
Cash and Cash Equivalents0.280.440.230.560.160.09
Short-Term Investments0.570.750.850.410.140.00
Cash & Short-Term Investments0.850.441.080.970.300.09
Accounts Receivable0.000.000.000.300.000.00
Inventory0.000.000.000.000.000.00
Other Current Assets0.030.750.010.010.010.00
Total Current Assets0.881.211.091.270.310.09
Non-Current Assets
Property, Plant & Equipment (Net)0.220.240.230.190.130.04
Other Non-Current Assets0.010.010.010.010.020.02
Total Non-Current Assets0.230.250.250.200.280.06
Total Assets1.101.461.341.470.450.16
Current Liabilities
Accounts Payable0.000.000.010.010.010.01
Short-Term Debt0.010.000.000.000.000.00
Accrued Liabilities0.020.040.020.050.010.00
Deferred Revenue0.110.070.140.090.000.00
Other Current Liabilities0.020.110.030.050.080.01
Total Current Liabilities0.180.210.220.210.100.03
Non-Current Liabilities
Long-Term Debt0.150.160.170.000.100.03
Other Non-Current Liabilities0.000.000.010.040.000.00
Total Non-Current Liabilities0.190.270.380.430.100.03
Total Liabilities0.370.480.610.650.210.06
Stockholders' Equity
Common Stock0.000.000.000.000.000.00
Retained Earnings-1.57-1.19-1.06-0.77-0.40-0.20
Accumulated Other Comprehensive Income0.000.000.000.000.000.00
Additional Paid-in Capital2.302.171.791.590.640.00
Shares Outstanding0.080.080.070.070.000.00
Total Stockholders' Equity0.730.980.730.830.250.10
Total Liabilities & Equity1.101.461.341.470.450.16